Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) - Concepedia

Concepedia

Publication | Closed Access

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

1.5K

Citations

25

References

2009

Year

John B. Buse, Julio Rosenstock, Giorgio Sesti, Wolfgang E. Schmidt, Eduard Montanya, Jason Brett, Marcin Zychma, Lawrence Blonde

Open-label TrialDiabetes ManagementMedicineDiabetesClinical TrialsType 2PharmacotherapyDiabetes MellitusPharmacology

References

	Year	Citations

Page 1